Lucira Health, Inc. Form 4 (March 1, 2022)

Summary

A Form 4 Statement of Changes in Beneficial Ownership for Lucira Health, Inc. [LHDX], filed for Debkishore Mitra, who is marked as a Director and as an officer with the title Chief Technology Officer. Table I reports 890 shares of common stock sold on 03/01/2022 at $4.68 and 186 shares sold on 06/01/2022 at $1.85, both under transaction code S, leaving 382,399 shares owned directly. The explanation states that the shares were sold to cover tax withholding obligations on the vesting of Restricted Stock Units granted on March 10, 2021 for 8,250 shares. The holdings include 1,470 shares and 2,552 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan. The signature is /s/ Dan George, Attorney-in-Fact for Debkishore Mitra, Ph.D., dated 07/12/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Mitra Debkishore (Last) (First) (Middle) 1412 62ND STREET (Street) EMERYVILLE CA 94608 (City) (State) (Zip) | Mitra Debkishore | (Last) | (First) | (Middle) | 1412 62ND STREET | EMERYVILLE | CA | 94608 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Lucira Health, Inc. [ LHDX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Technology Officer | X | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Chief Technology Officer
3. Date of Earliest Transaction
 (Month/Day/Year) 03/01/2022
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 03/01/2022 | S | 890 (1) | D | $ 4.68 | 382,585 (2) | D
Common Stock | 06/01/2022 | S | 186 (1) | D | $ 1.85 | 382,399 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Explanation of Responses:
1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 10, 2021 for 8,250 shares.
2. Includes 1,470 shares and 2,552 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 20, 2021 and February 20, 2022, respectively.
Remarks:
/s/ Dan George, Attorney-in-Fact for Debkishore Mitra, Ph.D. | 07/12/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_LHDX_4_filed2022-07-12_0001209191-22-041964.xml

Size

16,108 bytes

SHA-256

26c7e0c25f6fbe554e9d9b419bdc56d63d5318c95faff10d658363fe36483970

Our copy

SEC_LHDX_4_filed2022-07-12_0001209191-22-041964.xml

Original

www.sec.gov